PartsTable
Technical Data Sheet
Download PDF

NDC42367-0540-32 — DANTROLENE SODIUM FOR INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC42367-0540-32: DANTROLENE SODIUM FOR INJECTION.

DANTROLENE SODIUM FOR INJECTION. Key specifications include physical_form: POWDER, administration: INTRAVENOUS, primary_container_type: VIAL, protective_storage_feature: CONTROLLED ROOM TEMPERATURE, primary_container_content_quantity: 250.0 MILLIGRAMS OF ACTIVE INGREDIENT, active_medicament_medicinal_strength: 250.0 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-653-1569, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC42367-0540-32
NSN: 6505-01-653-1569
FSC: 6505 — Drugs and Biologicals
CAGE: 7LL94 — EAGLE PHARMACEUTICALS, INC. (USA)
SPECIFICATIONS
usual_dose2.5 MG/KG ADMINISTERED INTRAVENOUSLY OVER A PERIOD OF AT LEAST 1 MINUTE, STARTING APPROXIMATELY 75 MINUTES PRIOR TO SURGERY
physical_formPOWDER
administrationINTRAVENOUS
primary_container_typeVIAL
protective_storage_featureCONTROLLED ROOM TEMPERATURE
primary_container_content_quantity250.0 MILLIGRAMS OF ACTIVE INGREDIENT
active_medicament_medicinal_strength250.0 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyRYANODEX (DANTROLENE SODIUM) INJECTION 250MG
NSN6505-01-653-1569
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available DANTROLENE SODIUM FOR INJECTION TITLE COMPONENT PN NDC42367-0540-32 MFR DANTROLENE SODIUM FOR
KEY FEATURES
•
ADMINISTRATION: INTRAVENOUS
•
PRIMARY CONTAINER CONTENT QUANTITY: 250.0 MILLIGRAMS OF ACTIVE INGREDIENT
•
USUAL DOSE: 2.5 MG/KG ADMINISTERED INTRAVENOUSLY OVER A PERIOD OF AT LEAST 1 MINUTE, STARTING APPROXIMATELY 75 MINUTES PRIOR TO SURGERY
•
PRIMARY CONTAINER TYPE: VIAL
•
PHYSICAL FORM: POWDER
•
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
TECHNICAL CHARACTERISTICS
ADMINISTRATIONINTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY250.0 MILLIGRAMS OF ACTIVE INGREDIENT
USUAL DOSE2.5 MG/KG ADMINISTERED INTRAVENOUSLY OVER A PERIOD OF AT LEAST 1 MINUTE, STARTING APPROXIMATELY 75 MINUTES PRIOR TO SURGERY
PRIMARY CONTAINER TYPEVIAL
PHYSICAL FORMPOWDER
SPECIAL FEATURESDANTROLENE SODIUM 250MG FOR RECONSTITUTION WITH 5ML STERILE WATER FOR INJECTION; (WITHOUT A BACTERIOSTATIC AGENT); STORE UNRECONSTITUTED PRODUCT AT 20 TO 25 DEGREES CELSIUS (68-77 DEGREES FAHRENHEIT) - USP CONTROLLED ROOM TEMPERATURE; AVOID EXPOSURE TO LIGHT; MUST USE THE CONTENTS OF THE VIAL WITHIN 6 HOURS AFTER RECONSTITUTION; MANUFACTURER, EAGLE PHARMACEUTICALS DOES NOT HAVE A CAGE CODE.
PROTECTIVE STORAGE FEATURECONTROLLED ROOM TEMPERATURE
PART NAME ASSIGNED BY CONTROLLING AGENCYRYANODEX (DANTROLENE SODIUM) INJECTION 250MG
ACTIVE MEDICAMENT MEDICINAL STRENGTH250.0 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT
SUBSTITUTES & CROSS-REFERENCES 2
6505NCM162633Reference document
Same NSN cross-reference
Reference document — Secondary reference
1398188Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC42367-0540-32?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC42367-0540-32?
NDC42367-0540-32 is a DANTROLENE SODIUM FOR INJECTION.
What parts can replace NDC42367-0540-32?
There are 2 known substitutes for NDC42367-0540-32: 6505NCM162633, 1398188. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC42367-0540-32?
NDC42367-0540-32 is cataloged in the U.S. Government catalog under NSN 6505-01-653-1569. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC42367-0540-32